Article Details

Roche to acquire Flatiron Health to accelerate development of cancer medications

Retrieved on: 2018-02-16 05:33:45

Tags for this article:

Click the tags to see associated articles and topics

Roche to acquire Flatiron Health to accelerate development of cancer medications. View article details on hiswai:

Excerpt

<div>Basel, 15 February 2018 -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and <b>Flatiron</b> <b>Health</b>, Inc. announced today that the two partners have signed a definitive agreement under which Roche will acquire all shares of <b>Flatiron Health</b>, following on from an existing equity stake of 12.6%. The transaction is ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo